ASCIRES

What ASCIRES does

ASCIRES (operating under the legal entity ECG Médica S.L.) is a privately held Spanish biomedical group headquartered in Valencia that operates across Diagnostic Imaging, Nuclear Medicine, Medical Genetics, and Image-Guided Radiotherapy. The group serves both individual patients through its owned Clínicas Biomédicas network and Hospital Ascires, and external public and private hospitals that purchase its biomedical diagnostic services. The newly opened Hospital Ascires in Valencia represents a €125 million capital project spanning 30,000 square meters; its first phase commenced External Consultations and Diagnostic Imaging services in November 2025. Additional operational sites include the ASCIRES CETIR Viladomat European Reference Technology Center in Barcelona and ENS-certified medical centers in Madrid, alongside 50+ years of accumulated imaging expertise and pioneer status in Spanish Medical Genetics.

The group's underlying technology combines conventional imaging modalities (CT, MRI, PET, X-ray), nuclear medicine, and genetic testing with a portfolio of proprietary AI-driven diagnostic tools and biomarkers. Named products include PITAGOR-AI (scoliosis radiological assessment), EpiQUANT (cardiovascular risk from epicardial fat), breast cancer AI (96% false-negative avoidance), coronary risk AI (CT-based prediction), a digital twin of the aorta, COVIDTools (genomic plus imaging COVID-19 analytics), and the fusion biopsy technique for prostate cancer (96% detection). On the clinical technology side, Ascires operates advanced modalities including Neuro-HIFU (for movement disorders such as essential tremor and Parkinson's disease), image-guided radiotherapy, the Lattice radiotherapy project, and the ALBA project for ultra-low-dose radiotherapy in inflammatory diseases.

ASCIRES generates revenue principally through professional service fees charged for diagnostic, imaging, radiotherapy, genetics, cardiology, and sports medicine procedures, on a hybrid direct-to-consumer and B2B go-to-market. Patients schedule through the Mi Espacio Ascires portal and receive results via SMS code, while corporate contracts serve public and private hospitals. The company is led by CEO Lorena Saus, has 101–250 employees, and pursues an R&D-intensive growth strategy anchored in Joint Research Units with Universitat Politècnica de València and Universidad CEU Cardenal Herrera, an IBQUAES partnership on AI algorithms and the first MRI simulator in Europe, and non-dilutive funding from the Agencia Valenciana de la Innovación and regional innovation agencies.

Name

ASCIRES

Legal name

ECG Médica S.L.

Website

https://ascires.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

101–250 employees

Short description

ASCIRES is a privately held Spanish biomedical group operating Hospital Ascires in Valencia, Clínicas Biomédicas clinics, and European reference centers in Barcelona and Madrid, providing diagnostic imaging, nuclear medicine, genetics, image-guided radiotherapy, and proprietary AI tools to individual patients and public/private hospitals.

Ownership category

akta.pro rank

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: Medical imaging services including MRI, CT scans, X-rays, and other diagnostic imaging modalities offered through clinic network and hospital
2. Medical Genetics Services: Genetic testing and medical genetics consultations for oncology, cardiology, neurology, and reproduction specialties
3. Radiotherapy Services: Image-guided radiotherapy treatments including advanced techniques like Neuro-HIFU and ultra-low dose radiotherapy for inflammatory diseases
4. Nuclear Medicine: Nuclear medicine services as part of the comprehensive diagnostic offering

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ASCIRES is Spain's pioneering biomedical group providing diagnostic imaging, nuclear medicine, medical genetics, and image-guided radiotherapy services. The company operates through Hospital Ascires in Valencia, a network of Clínicas Biomédicas, and delivers proprietary AI-powered diagnostic tools and biomarkers for precision medicine. It serves both individual patients directly and provides biomedical services to public and private hospitals.

Product overview

Ascires Grupo Biomédico is Spain's pioneering biomedical group in Medical Imaging (Diagnóstico por Imagen), Nuclear Medicine, Medical Genetics, and Image-Guided Radiotherapy. The company operates as an integrated healthcare network combining Hospital Ascires (€125 million facility in Valencia), a network of Clínicas Biomédicas, and advanced AI-powered diagnostic tools. The portfolio includes core medical services (imaging, nuclear medicine, genetics, radiotherapy, cardiology, sports medicine) alongside proprietary AI modules (PITAGOR-AI for scoliosis, EpiQUANT for cardiovascular risk, COVIDTools, AI breast cancer detection, coronary risk prediction) and innovative treatments (Neuro-HIFU, fusion biopsy, Lattice radiotherapy, ALBA project, digital twin of aorta). The ecosystem integrates genomic, clinical, and imaging data through proprietary AI algorithms for precision medicine diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• Ascires: Main brand for biomedical diagnostic and genetic services
• Hospital Ascires
• Clínicas Biomédicas Ascires

Products and services

• Diagnostic Imaging Services (Diagnóstico por Imagen) Advanced medical imaging services including CT, MRI, PET, and conventional radiology for comprehensive diagnostic evaluation of patients and hospital referrals.
• Nuclear Medicine (Medicina Nuclear) Nuclear medicine diagnostic and therapeutic services for various medical conditions, including theragnostics combining diagnostics and therapy.
• Medical Genetics (Genética Médica) Genetic testing and counseling services for inherited conditions, cancer risk assessment, and personalized medicine, serving oncology, cardiology, neurology, and reproduction specialties.
• Image-Guided Radiotherapy (Radioterapia Guiada por Imagen) Advanced radiotherapy treatments guided by medical imaging for precise tumor targeting, including Lattice radiotherapy for complex tumors and ALBA project for inflammatory diseases.
• Hospital Ascires First biomedical hospital of Ascires in Valencia, offering comprehensive medical services including 24-hour emergency care, cardiology, and complex pathology detection and treatment.
• Clínicas Biomédicas Ascires Network of biomedical clinics providing specialized medical services with advanced imaging technology and genetic services across multiple specialties.
• Neuro-HIFU Treatment

Quantifiable outcome

• Fusion biopsy detects 96% of prostate cancer cases, 40% more than conventional methods
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Partnerships

Six partnerships are on record, tiered minor and core.

• IVRE+minorStrategic or Co-development Partner · 1 December 2024Partnership to create a Sports Medicine Unit combining cardiology, traumatology, sports medicine, radiology, physiotherapy, nutrition, and physical preparation expertise.
• Universitat Politècnica de València (UPV)coreStrategic or Co-development PartnerAscires and UPV created a Joint Research Unit (Unidad Mixta de Investigación) to advance precision medicine research, combining Ascires' biomedical expertise with UPV's technical capabilities.
• Universidad CEU Cardenal Herrera (CEU UCH)coreStrategic or Co-development PartnerAscires and CEU UCH created a Joint Research Unit in precision medicine, with CEO Lorena Saus signing the agreement, focusing on biomedical innovation and research.
• IBQUAEScoreStrategic or Co-development PartnerAscires and IBQUAES collaborate on biomedical technology development, including algorithms, Neuro-HIFU technique, and first MRI simulator in Europe. The Ministry of Science and Innovation showed interest in this technology.
• Agencia Valenciana de la InnovacióncoreStrategic or Co-development PartnerFinancial and strategic support for innovative projects including digital twin of aorta development and virtual liver biopsy biomarkers.
• Cátedra UB-CETIR/QUAESminorStrategic or Co-development PartnerOrganized the first symposium on teragnostics in Spain, advancing the role of nuclear oncologist in Spain.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Affidea: European outpatient diagnostic imaging and radiotherapy provider operating across multiple countries. Closest pan-European comparable to Ascires' diagnostic imaging + radiotherapy platform model, with similar specialty-center economics.
• Quirónsalud: Spain's largest private hospital group, operating a nationwide network of general hospitals and specialty centers. Comparable to Ascires as a Spanish private healthcare provider with multi-specialty clinical services, though at materially greater scale and broader service coverage.
• GenesisCare: Global private oncology and radiotherapy provider with Spanish operations. Direct overlap with Ascires' image-guided radiotherapy franchise and oncology positioning; comparable business model combining advanced radiotherapy with AI-enabled planning.
• HM Hospitales: Private hospital group in Spain with strong presence in Madrid and Barcelona, including oncology, imaging, and specialty care. Overlaps with Ascires on the diagnostic imaging, oncology, and cardiology service lines, particularly in the Madrid market.
• Vithas: Spanish private hospital group with 20+ hospitals and a strong specialty footprint including oncology and diagnostic imaging. Comparable as a private multi-site Spanish provider competing for the same patient referral pool and B2B hospital contracts.
• Hospital Ribera: Spanish private hospital operator with multi-site presence and public-private partnership exposure. Comparable as a private Spanish provider competing for the same regional and specialty care demand that Ascires serves.
• Tecknon (Centro Médico Teknon): Barcelona-based premium private hospital with strong imaging, oncology, and specialty care. Direct overlap with Ascires' Barcelona CETIR Viladomat operations and the high-complexity private patient market in Catalonia.

Regional players

• Capio / Fundación Jiménez Díaz: Madrid-based reference hospital (Quirónsalud group historically tied to Capio model) with strong diagnostic and specialty services. Comparable for Spanish specialty/diagnostic competition, particularly relevant given Ascires' Madrid presence.

Emerging players

• Inceptua / European Medical Solutions: European emerging players offering AI-driven diagnostic imaging and precision medicine solutions. Comparable to the AI-enabled diagnostic arm of Ascires (PITAGOR-AI, EpiQUANT, breast cancer AI) as a potential licensor/competitor in medical imaging AI.

Broad incumbents

• Sanitas (hospitales): Part of Bupa, Sanitas operates hospitals and clinics across Spain with a broader health-insurance-integrated offering. Comparable as a large incumbent Spanish private healthcare group, though bundled with insurance which Ascires does not offer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCZUQCyZkxDrFwkJFOywnMsQ
• LinkedInlinkedin.com/company/ascires-grupo-biomedico

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ASCIRES